• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白精氨酸甲基转移酶:癌症治疗的有前途靶点。

Protein arginine methyltransferases: promising targets for cancer therapy.

机构信息

Research Institute of Pharmaceutical Sciences, College of Pharmacy, Sookmyung Women's University, Seoul, 04310, Republic of Korea.

Natural Product Research Institute, Korea Institute of Science and Technology, Gangneung, 25451, Republic of Korea.

出版信息

Exp Mol Med. 2021 May;53(5):788-808. doi: 10.1038/s12276-021-00613-y. Epub 2021 May 18.

DOI:10.1038/s12276-021-00613-y
PMID:34006904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8178397/
Abstract

Protein methylation, a post-translational modification (PTM), is observed in a wide variety of cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic research, the importance of protein methylation has been highlighted. The methylation of histone proteins that contributes to the epigenetic histone code is not only dynamic but is also finely controlled by histone methyltransferases and demethylases, which are essential for the transcriptional regulation of genes. In addition, many nonhistone proteins are methylated, and these modifications govern a variety of cellular functions, including RNA processing, translation, signal transduction, DNA damage response, and the cell cycle. Recently, the importance of protein arginine methylation, especially in cell cycle regulation and DNA repair processes, has been noted. Since the dysregulation of protein arginine methylation is closely associated with cancer development, protein arginine methyltransferases (PRMTs) have garnered significant interest as novel targets for anticancer drug development. Indeed, several PRMT inhibitors are in phase 1/2 clinical trials. In this review, we discuss the biological functions of PRMTs in cancer and the current development status of PRMT inhibitors in cancer therapy.

摘要

蛋白质甲基化是一种翻译后修饰(PTM),存在于从原核生物到真核生物的各种细胞类型中。随着表观遗传学研究的迅速发展,蛋白质甲基化的重要性得到了强调。组蛋白蛋白的甲基化有助于表观遗传组蛋白密码,不仅是动态的,而且还受到组蛋白甲基转移酶和去甲基酶的精细调控,这些酶对于基因的转录调控至关重要。此外,许多非组蛋白蛋白也被甲基化,这些修饰调控着多种细胞功能,包括 RNA 加工、翻译、信号转导、DNA 损伤反应和细胞周期。最近,人们注意到蛋白质精氨酸甲基化的重要性,特别是在细胞周期调控和 DNA 修复过程中。由于蛋白质精氨酸甲基化的失调与癌症的发展密切相关,因此精氨酸甲基转移酶(PRMTs)作为新型抗癌药物开发的靶点引起了广泛关注。事实上,已有几种 PRMT 抑制剂进入 1/2 期临床试验。在这篇综述中,我们讨论了 PRMTs 在癌症中的生物学功能以及 PRMT 抑制剂在癌症治疗中的最新发展状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/6e24fc958f6f/12276_2021_613_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/34f3159e9c77/12276_2021_613_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/c9758a4f0ee1/12276_2021_613_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/d7052cf3b3b1/12276_2021_613_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/6e24fc958f6f/12276_2021_613_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/34f3159e9c77/12276_2021_613_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/c9758a4f0ee1/12276_2021_613_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/d7052cf3b3b1/12276_2021_613_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d6/8178397/6e24fc958f6f/12276_2021_613_Fig4_HTML.jpg

相似文献

1
Protein arginine methyltransferases: promising targets for cancer therapy.蛋白精氨酸甲基转移酶:癌症治疗的有前途靶点。
Exp Mol Med. 2021 May;53(5):788-808. doi: 10.1038/s12276-021-00613-y. Epub 2021 May 18.
2
Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.蛋白质精氨酸甲基转移酶的非组蛋白精氨酸甲基化。
Curr Protein Pept Sci. 2020;21(7):699-712. doi: 10.2174/1389203721666200507091952.
3
PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?PRMTs 和精氨酸甲基化:癌症的最佳秘密?
Trends Mol Med. 2019 Nov;25(11):993-1009. doi: 10.1016/j.molmed.2019.05.007. Epub 2019 Jun 20.
4
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.蛋白质精氨酸甲基转移酶在克服抗癌药物耐药性方面的潜在作用。
Drug Resist Updat. 2024 Jan;72:101016. doi: 10.1016/j.drup.2023.101016. Epub 2023 Nov 3.
5
Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.鉴定 hnRNP-A1 作为 I 型 PRMT 抑制在血液和肿瘤组织中的药效生物标志物。
Sci Rep. 2020 Dec 17;10(1):22155. doi: 10.1038/s41598-020-78800-6.
6
The regulation, functions and clinical relevance of arginine methylation.精氨酸甲基化的调控、功能和临床相关性。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):642-657. doi: 10.1038/s41580-019-0155-x. Epub 2019 Jul 26.
7
Arginine Methylation: The Coming of Age.精氨酸甲基化:崭露头角。
Mol Cell. 2017 Jan 5;65(1):8-24. doi: 10.1016/j.molcel.2016.11.003.
8
Arginine methylation and respiratory disease.精氨酸甲基化与呼吸疾病。
Transl Res. 2024 Oct;272:140-150. doi: 10.1016/j.trsl.2024.03.002. Epub 2024 Mar 5.
9
Arginine methylation: the promise of a 'silver bullet' for brain tumours?精氨酸甲基化:脑瘤的“银弹”之梦?
Amino Acids. 2021 Apr;53(4):489-506. doi: 10.1007/s00726-020-02937-x. Epub 2021 Jan 6.
10
Mechanisms and Inhibitors of Histone Arginine Methylation.组蛋白精氨酸甲基化的机制和抑制剂。
Chem Rec. 2018 Dec;18(12):1792-1807. doi: 10.1002/tcr.201800082. Epub 2018 Sep 19.

引用本文的文献

1
Current and Emerging Therapies for Targeting Protein Arginine Methyltransferases (PRMTs) in Cancer.用于靶向癌症中蛋白质精氨酸甲基转移酶(PRMTs)的当前及新兴疗法
Int J Mol Sci. 2025 Aug 16;26(16):7907. doi: 10.3390/ijms26167907.
2
Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS/STING signaling in gastric cancer cells.肿瘤来源的PRMT1通过抑制胃癌细胞中的cGAS/STING信号通路来抑制巨噬细胞的抗肿瘤活性。
Cell Death Dis. 2025 Aug 26;16(1):649. doi: 10.1038/s41419-025-07960-y.
3
Therapeutic targeting of protein arginine methyltransferases reduces breast cancer progression by disrupting angiogenic pathways.

本文引用的文献

1
Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription.靶向甲基转移酶 PRMT5 通过表观遗传抑制 Twist1 转录来延缓头颈鳞状细胞癌的发生和转移。
Neoplasia. 2020 Nov;22(11):617-629. doi: 10.1016/j.neo.2020.09.004. Epub 2020 Oct 10.
2
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.蛋白质精氨酸甲基转移酶5在去势抵抗性前列腺癌中促进pICln依赖性雄激素受体转录
Cancer Res. 2020 Nov 15;80(22):4904-4917. doi: 10.1158/0008-5472.CAN-20-1228. Epub 2020 Sep 30.
3
对蛋白质精氨酸甲基转移酶的治疗性靶向通过破坏血管生成途径来降低乳腺癌进展。
Biochem Biophys Rep. 2025 Jul 31;43:102172. doi: 10.1016/j.bbrep.2025.102172. eCollection 2025 Sep.
4
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.表观药物筛选确定I型蛋白精氨酸甲基转移酶(PRMT)抑制剂为癌症中溶酶体胞吐作用和药物敏感性的调节剂。
Cell Death Dis. 2025 Aug 8;16(1):600. doi: 10.1038/s41419-025-07900-w.
5
Protein Arginine Methyltransferase 1-mediated Histone H4R3 Dimethyl Asymmetric enhances Epidermal Growth Factor Receptor signaling to promote Peritoneal Fibrosis.蛋白质精氨酸甲基转移酶1介导的组蛋白H4R3不对称二甲基化增强表皮生长因子受体信号传导以促进腹膜纤维化。
Int J Biol Sci. 2025 Jun 9;21(9):4010-4026. doi: 10.7150/ijbs.114037. eCollection 2025.
6
Emerging roles of protein arginine methyltransferase in multiple myeloma.蛋白质精氨酸甲基转移酶在多发性骨髓瘤中的新作用。
Mol Ther Oncol. 2025 May 26;33(2):201003. doi: 10.1016/j.omton.2025.201003. eCollection 2025 Jun 18.
7
Molecular Imprints of Clinical Comorbidities in Hypothalamic Extracellular Vesicles at the Onset of Obesity.肥胖症发病时下丘脑细胞外囊泡中临床合并症的分子印记
ACS Omega. 2025 May 29;10(22):23563-23581. doi: 10.1021/acsomega.5c02274. eCollection 2025 Jun 10.
8
MicroRNA-100-5p Exacerbates Myocardial Ischemia-Reperfusion Injury Through Downregulation of PRMT5.微小RNA-100-5p通过下调PRMT5加重心肌缺血再灌注损伤。
FASEB J. 2025 Jun 15;39(11):e70690. doi: 10.1096/fj.202403196R.
9
Protein Arginine Methyltransferases from Regulatory Function to Clinical Implication in Central Nervous System.从调节功能到中枢神经系统临床意义的蛋白质精氨酸甲基转移酶
Cell Mol Neurobiol. 2025 May 14;45(1):41. doi: 10.1007/s10571-025-01546-0.
10
Regulation of protein arginine methyltransferase in osteoporosis: a narrative review.蛋白质精氨酸甲基转移酶在骨质疏松症中的调控:一篇叙述性综述。
Front Cell Dev Biol. 2025 Apr 24;13:1453624. doi: 10.3389/fcell.2025.1453624. eCollection 2025.
PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
PRMT5 介导的 YBX1 甲基化调控结直肠癌中的 NF-κB 活性。
Sci Rep. 2020 Sep 28;10(1):15934. doi: 10.1038/s41598-020-72942-3.
4
PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.PRMT6 在肺腺癌中通过调节 p18 发挥致癌作用。
Mol Med Rep. 2020 Oct;22(4):3161-3172. doi: 10.3892/mmr.2020.11402. Epub 2020 Aug 3.
5
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.PRMT1 介导的 EZH2 甲基化调控其稳定性并促进乳腺癌转移。
Cell Death Differ. 2020 Dec;27(12):3226-3242. doi: 10.1038/s41418-020-00615-9. Epub 2020 Sep 7.
6
Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders.发现首例靶向蛋白质精氨酸甲基转移酶 5(PRMT5)的降解剂。
J Med Chem. 2020 Sep 10;63(17):9977-9989. doi: 10.1021/acs.jmedchem.0c01111. Epub 2020 Aug 21.
7
PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation.PRMT5 通过 53BP1 的甲基化促进 DNA 修复,并且受Src 介导的磷酸化调控。
Commun Biol. 2020 Aug 5;3(1):428. doi: 10.1038/s42003-020-01157-z.
8
Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics.HSP70 的甲基化调控其与 BCL2 mRNA 的结合和稳定,使胰腺癌细胞对治疗产生抗性。
Cancer Res. 2020 Oct 15;80(20):4500-4513. doi: 10.1158/0008-5472.CAN-19-1738. Epub 2020 Jul 22.
9
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas.CARM1 抑制降低组蛋白乙酰转移酶活性,导致 CREBBP/EP300 突变淋巴瘤的合成致死。
Leukemia. 2020 Dec;34(12):3269-3285. doi: 10.1038/s41375-020-0908-8. Epub 2020 Jun 24.
10
Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.药理学抑制 PRMT7 将精氨酸单甲基化与细胞应激反应联系起来。
Nat Commun. 2020 May 14;11(1):2396. doi: 10.1038/s41467-020-16271-z.